Evonik achieved exceptional results in the second quarter of 2026. Adjusted EBITDA rose by 24 % compared to the same period of the previous year, reaching 630 million EUR. The group now anticipates adjusted EBITDA between 2.0 and 2.2 billion EUR – a notable jump from the previous target range of 1.7 to 2.0 billion EUR. Free cash flow also showed positive development in the second quarter. At 49 million EUR, it was significantly better than in the previous year’s quarter (minus 211 million EUR).